Board of Directors Archives – SPR Therapeutics

Robert M. Blankenship

Managing Director

Bob Blankenship served as Chief Financial Officer of NDI Medical from 2005 through 2012, managing the company’s finances, budgets, tax…

Nicholas J. Valeriani

Managing Director

Mr. Valeriani is the retired chief executive officer of the Gary and Mary West Health Institute, an independent, nonprofit medical…

Geoffrey B. Thrope

Chairman

Mr. Thrope is the founder, president and CEO of NDI. He has more than 30 years of neurodevice experience conducting…

Michael P. Chuisano

Managing Director

Mr. Chuisano is a retired senior executive having spent over 36 years at Johnson & Johnson. He brings diversified business…

Maria E. Bennett

President, CEO and Founder

Maria (Walker) Bennett has led SPR Therapeutics since its inception. Prior to the formation of SPR, Ms. Bennett served as…

The SPRINT PNS System is indicated for up to 60 days in the back and/or extremities for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to treat pain in the craniofacial region. Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.

View References for support of all claims.

The SPRINT^® PNS System, MicroLead^™, OnePass Introducer^™, Rethink Your Pain Strategy^™, Outsmart Pain^™, Sustained Pain Relief Starts Here^™, Life. Get Back to It.^™ and SPR^® are registered or common law trademarks of SPR Therapeutics, Inc.